Open-Label Study of Setmelanotide in Hypothalamic Obesity
Clinical trial NCT04725240 · COMPLETED
Trial details
- NCT number
- NCT04725240
- Sponsor
- Rhythm Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-07
- Primary completion
- 2022-06-28
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.